Related Experiment Videos
Subependymal giant-cell astrocytoma. Case report with ultrastructural study
Journal of Neurosurgery
|February 1, 1979
Summary
A rare subependymal giant-cell astrocytoma caused a brain obstruction in a 13-year-old boy diagnosed with tuberous sclerosis. Ultrastructural analysis revealed novel tumor cell features, expanding knowledge of this rare condition.
Area of Science:
- Neuro-oncology
- Pediatric Neurology
- Pathology
Background:
- Tuberous sclerosis is a genetic disorder that can lead to the development of tumors in various organs, including the brain.
- Subependymal giant-cell astrocytomas (SEGAs) are typically benign tumors arising from the brain's ventricular system, often associated with tuberous sclerosis.
- Intraventricular masses can cause significant neurological deficits due to obstruction of cerebrospinal fluid flow.
Observation:
- A 13-year-old male presented with symptoms of an obstructive left lateral intraventricular mass.
- Pathological examination confirmed the mass as a subependymal giant-cell astrocytoma.
- Clinical investigations further corroborated the diagnosis of tuberous sclerosis.
Findings:
- Ultrastructural examination of the tumor revealed features consistent with previously described subependymal giant-cell astrocytomas.
- Novel findings included the identification of tumor cells containing large dense granulated bodies and dense-core vesicles, not previously documented in this tumor type.
- These ultrastructural findings contribute to a deeper understanding of SEGA cellular morphology.
Implications:
- The identification of novel ultrastructural features in SEGA may aid in refining diagnostic criteria and understanding tumor behavior.
- This case highlights the importance of comprehensive histopathological and ultrastructural analysis in diagnosing and characterizing brain tumors, particularly in the context of genetic syndromes like tuberous sclerosis.
- Further research into these unique cellular components could offer insights into potential therapeutic targets for SEGAs.